Search by Drug Name or NDC

    NDC 51660-0071-36 Guaifenesin and Pseudoephedrine Hydrochloride 600; 60 mg/1; mg/1 Details

    Guaifenesin and Pseudoephedrine Hydrochloride 600; 60 mg/1; mg/1

    Guaifenesin and Pseudoephedrine Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by OHM LABORATORIES INC. The primary component is GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 51660-0071
    Product ID 51660-071_e0cbdc72-78c1-4372-a09d-de74c383dbbf
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Guaifenesin and Pseudoephedrine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin and Pseudoephedrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 600; 60
    Active Ingredient Units mg/1; mg/1
    Substance Name GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name OHM LABORATORIES INC
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021585
    Listing Certified Through 2022-12-31

    Package

    NDC 51660-0071-36 (51660007136)

    NDC Package Code 51660-071-36
    Billing NDC 51660007136
    Package 2 BLISTER PACK in 1 CARTON (51660-071-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2017-12-10
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 400252ae-fe27-4f82-87f3-ead7eff335de Details

    Revised: 6/2019